The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
The P190, P210, and P230 Forms of the BCR/ABL Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic Activity
Open accessAbstract
The product of the Philadelphia chromosome (Ph) translocation, the BCR/ABL oncogene, exists in three principal forms (P190, P210, and P230 BCR/ABL) that are found in distinct forms of Ph-positive leukemia, suggesting the three proteins have different leukemogenic activity. We have directly compared the tyrosine kinase activity, in vitro transformation properties, and in vivo leukemogenic activity of the P190, P210, and P230 forms of BCR/ABL. P230 exhibited lower intrinsic tyrosine kinase activity than P210 and P190. Although all three oncogenes transformed both myeloid (32D cl3) and lymphoid (Ba/F3) interleukin (IL)-3–dependent cell lines to become independent of IL-3 for survival and growth, their ability to stimulate proliferation of Ba/F3 lymphoid cells differed and correlated directly with tyrosine kinase activity. In a murine bone marrow transduction/transplantation model, the three forms of BCR/ABL were equally potent in the induction of a chronic myeloid leukemia (CML)–like myeloproliferative syndrome in recipient mice when 5-fluorouracil (5-FU)–treated donors were used. Analysis of proviral integration showed the CML-like disease to be polyclonal and to involve multiple myeloid and B lymphoid lineages, implicating a primitive multipotential target cell. Secondary transplantation revealed that only certain minor clones gave rise to day 12 spleen colonies and induced disease in secondary recipients, suggesting heterogeneity among the target cell population. In contrast, when marrow from non– 5-FU–treated donors was used, a mixture of CML-like disease, B lymphoid acute leukemia, and macrophage tumors was observed in recipients. P190 BCR/ABL induced lymphoid leukemia with shorter latency than P210 or P230. The lymphoid leukemias and macrophage tumors had provirus integration patterns that were oligo- or monoclonal and limited to the tumor cells, suggesting a lineage-restricted target cell with a requirement for additional events in addition to BCR/ABL transduction for full malignant transformation. These results do not support the hypothesis that P230 BCR/ABL induces a distinct and less aggressive form of CML in humans, and suggest that the rarity of P190 BCR/ABL in human CML may reflect infrequent BCR intron 1 breakpoints during the genesis of the Ph chromosome in stem cells, rather than intrinsic differences in myeloid leukemogenicity between P190 and P210.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Tidmarsh, G. F., Heimfeld, S., Whitlock, C. A., Weissman, I. L., & Müller‐Sieburg, C. E. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5946 · Cited by 48
RetractedTidmarsh, G. F., Heimfeld, S., Whitlock, C. A., Weissman, I. L., & Müller‐Sieburg, C. E. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2665-2671.1989 · Cited by 41
RetractedProduction of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Daley, G. Q., Van Etten, R. A., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 1,756
Self-citationStat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,628
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
GROFFEN, J., STEPHENSON, J., HEISTERKAMP, N., DEKLEIN, A., BARTRAM, C., & GROSVELD, G. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,599
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
Lugo, T. G., Pendergast, A.-M., Muller, A. J., & Witte, O. N. (1990) · Science · doi:10.1126/science.2408149 · Cited by 1,281
Morrison, S. J., & Weissman, I. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90037-x · Cited by 1,115
The distribution of colony‐forming cells among spleen colonies
Siminovitch, L., McCulloch, E. A., & Till, J. E. (1963) · Journal of Cellular and Comparative Physiology · doi:10.1002/jcp.1030620313 · Cited by 909
Melo, J. (1996) · Blood · doi:10.1182/blood.v88.7.2375.bloodjournal8872375 · Cited by 723
Daley, G. Q., & Baltimore, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9312 · Cited by 572
Self-citationInduction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.
Kelliher, M. A., McLaughlin, J., Witte, O. N., & Rosenberg, N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6649 · Cited by 514
Ilaria, R. L., & Van Etten, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31704 · Cited by 488
Self-citationHa, S., Karhi, K. K., Rayter, S., Heisterkamp, N., Eridani, S., Powle, R., Lawler, S. D., Groffen, J., Foulkes, J. G., Greaves, M. F., et al. (1987) · Nature · doi:10.1038/325635a0 · Cited by 434
Pane, F., Frigeri, F., Sindona, M., Luciano, L., Ferrara, F., Cimino, R., Meloni, G., Saglio, G. N., Salvatore, F., & Rotoli, B. (1996) · Blood · doi:10.1182/blood.v88.7.2410.bloodjournal8872410 · Cited by 387
Improved Methods of Retroviral Vector Transduction and Production for Gene Therapy
Kotani, H., Newton, P. B., Zhang, S., Chiang, Y. L., Otto, E., Weaver, L., Blaese, R. M., Anderson, W. F., & McGarrity, G. J. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.1-19 · Cited by 370
McLaughlin, J., Chianese, E., & Witte, O. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6558 · Cited by 367
Elefanty, A. G., Hariharan, I. K., & Cory, S. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08212.x · Cited by 344
A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus.
Rosenberg, N., & Baltimore, D. (1976) · The Journal of experimental medicine · doi:10.1084/jem.143.6.1453 · Cited by 291
kat: a high-efficiency retroviral transduction system for primary human T lymphocytes
Finer, M., Dull, T., Qin, L., Farson, D., & Roberts, M. (1994) · Blood · doi:10.1182/blood.v83.1.43.43 · Cited by 224
A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia
Fainstein, E., Marcelle, C., Rosner, A., Canaani, E., Gale, R. P., Dreazen, O., Smith, S., & Croce, C. M. (1987) · Nature · doi:10.1038/330386a0 · Cited by 194
Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
Mayer, B. J., & Baltimore, D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.2883 · Cited by 178
Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus.
Hawley, R. G., Fong, A. Z. C., Burns, B. F., & Hawley, T. S. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.4.1149 · Cited by 160
New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia
Saglio, G. N., Guerrasio, A., Rosso, C., et al. (1990) · Blood · doi:10.1182/blood.v76.9.1819.1819 · Cited by 152
Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice.
Gishizky, M. L., Johnson-White, J., & Witte, O. N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3755 · Cited by 148
McLaughlin, J., Chianese, E., & Witte, O. N. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.5.1866 · Cited by 144
P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
Melo, J. V., Myint, H., Galton, D. A. G., & Goldman, J. M. (1994) · PubMed · Cited by 143
Luskey, B., Rosenblatt, M., Zsebo, K. M., & Williams, D. E. (1992) · Blood · doi:10.1182/blood.v80.2.396.396 · Cited by 136
Blast crisis in a murine model of chronic myelogenous leukemia.
Daley, G. Q., Etten, R. A. V., & Baltimore, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11335 · Cited by 116
Self-citationOkuda, K., Golub, T. R., Gilliland, D. G., & Griffin, J. D. (1996) · PubMed · Cited by 115
Expression of c-abl in Philadelphia-positive acute myelogenous leukemia
Kurzrock, R., Shtalrid, M., Talpaz, M., Kloetzer, W. S., & Gutterman, J. U. (1987) · Blood · doi:10.1182/blood.v70.5.1584.1584 · Cited by 87
Kelliher, M. A., Knott, A., McLaughlin, J., Witte, O. N., & Rosenberg, N. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4710 · Cited by 86
Laneuville, P., Heisterkamp, N., & Groffen, J. (1991) · PubMed · Cited by 72
Ilaria, R. J., & Etten, R. A. V. (1995) · Blood · doi:10.1182/blood.v86.10.3897.bloodjournal86103897 · Cited by 71
Self-citationClonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice
Voncken, J., Morris, C. M., Pattengale, P. K., Dennert, G., Kikly, C., Groffen, J., & Heisterkamp, N. (1992) · Blood · doi:10.1182/blood.v79.4.1029.1029 · Cited by 68
Chen, S., Flandrin, G., Daniel, M., Valensi, F., Baranger, L., Grausz, D., Bernheim, A., Chen, Z., Sigaux, F., & Berger, R. (1988) · PubMed · Cited by 68
Selleri, L., Lindern, M. V., Hermans, A., Meijer, D., Torelli, G., & Grosveld, G. C. (1990) · Blood · doi:10.1182/blood.v75.5.1146.1146 · Cited by 62
Secker‐Walker, L. M., Cooke, H. M., Browett, P., Ca, S., Norton, J., Coustan‐Smith, E., & Hoffbrand, A. V. (1988) · Blood · doi:10.1182/blood.v72.2.784.784 · Cited by 62
Elefanty, A. G., & Cory, S. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1755 · Cited by 57
Tachibana, N., Raimondi, S. C., Lauer, S. J., Sartain, P., & Dow, L. W. (1987) · Blood · doi:10.1182/blood.v70.5.1458.1458 · Cited by 55
v-abl causes hematopoietic disease distinct from that caused by bcr-abl.
Scott, M. L., Etten, R. A. V., Daley, G. Q., & Baltimore, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6506 · Cited by 43
Self-citationDow, L. W., Tachibana, N., Raimondi, S. C., Lauer, S. J., Witte, O. N., & Clark, S. (1989) · Blood · doi:10.1182/blood.v73.5.1291.1291 · Cited by 29
Etten, R. A. V. (1993) · Cancer treatment and research · doi:10.1007/978-1-4615-3086-2_14 · Cited by 21
Molecular heterogeneity of adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Schaefer-Rego, K., Arlin, Z. A., Shapiro, L. G., et al. (1988) · PubMed · Cited by 21
Kelliher, M. A., Weckstein, D. J., Knott, A. G., Wortis, H. H., & Rosenberg, N. E. (1993) · PubMed · Cited by 15
Cited by
The molecular biology of chronic myeloid leukemia
Deininger, M. W. N., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,667
Cancer stem cells: an evolving concept
Nguyen, L. V., Vanner, R., Dirks, P., & Eaves, C. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3184 · Cited by 1,171
Demers, M., Krause, D. S., Schatzberg, D., Martinod, K., Voorhees, J. R., Fuchs, T. A., Scadden, D. T., & Wagner, D. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200419109 · Cited by 883
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
Ren, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1567 · Cited by 878
Mechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL
Azam, M., Latek, R. R., & Daley, G. Q. (2003) · Cell · doi:10.1016/s0092-8674(03)00190-9 · Cited by 613
Self-citation
Metadata
- Authors
- Li, S., Ilaria, R. L., Million, R. P., Daley, G. Q., & Van Etten, R. A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-05-03
- Volume
- 189
- Issue
- 9
- Pages
- 1399-1412
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2140155134
- Cited by
- 501
- References
- 45
- FWCI
- 12.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.